Effect of Levosimendan on Respiratory Muscle Function in Healthy Subjects (LSD1)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
use of any prescript medication
pre-existent muscle disease (congenital or acquired) or diseases / disorders know to be associated with myopathy including diabetes and auto-immune diseases.
pre-existent lung disease
pre-existent cardiac disease (based on history, electrocardiography and transthoracic echocardiography)
pregnancy, breast feeding
upper airway / esophageal pathology
phrenic nerve lesions
any metals in body (pacemaker, splinters, metal stiches)